SAHPRA says it will allow for use of ivermectin in compassionate-use casesThese will be controlled, and closely monitored by relevant healthcare practitionersGuidelines for the exceptional-use programme will soon be releasedThe South African Health Products Regulatory Authority said on Wednesday that it will allow for use of ivermectin in the treatment of Covid-19, in exceptional circumstances, in a "controlled, compassionate, access programme". "We have listened, and we have heard," SAHPRA CEO Dr Boitumelo Semete-Makokotlela said in a press briefing. She said the regulator was cognisant of the second wave, and understood the situation with practitioners, and the limited options available. Semete-Makokotlela said Sahpra has also engaged with the World Health Organization, who also agree that current information is limited, on the use of ivermectin in Covid-19. She did, however, acknowledge "positive trends" from studies being conducted, and that the regulator would continue to review available data.

Source: News 24 January 27, 2021 11:47 UTC